Monograph Details
|
|
Endocrine System
> Diabetes
|
|
GLUCAGEN |
| Manufacturer |
|
Novo Nordisk |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Antihypoglycemic. |
| Generic Name |
|
Glucagon (as HCl) (recombinant) 1mg; pwd for SC, IV, or IM inj after reconstitution. |
| Indications |
|
Severe hypoglycemic episodes in diabetics treated with insulin. |
| Adults and Children |
|
May give IV, IM, or SC. Hypoglycemia: <8yrs (<55 lbs): 0.5mg. >6yrs (>55 lbs): 1mg. Repeat if needed. |
| Contraindications |
|
Pheochromocytoma. Insulinoma. |
| Precautions |
|
Instruct caregivers in proper use. If ineffective, give IV glucose. Give oral carbohydrates after treatment. Insufficient hepatic glycogen reserves (eg, prolonged fasting, starvation, adrenal insufficiency, chronic hypoglycemia). As a diagnostic aid in diabetes or elderly with cardiac disease. Pregnancy (Cat.B). Nursing mothers. |
| Interactions |
|
β-blockers potentiate cardiac effects. Potentiates anticholinergics. |
| Adverse Reactions |
|
GI upset, tachycardia, transient increase in blood pressure, allergic reactions. |
| How Supplied |
HypoKit—1 (w. syringe + diluent)
Vials—10 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
